Business & Human Rights Resource Centre: ICCR AIDS responses

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.

Page Banner

  • Centro de Información sobre Empresas y Derechos Humanos
  • Centre de Ressources sur les Entreprises et les Droits de l'Homme

Site last updated Fri 29 Aug 2008

Skip the primary navigation if you do not want to read it as the next section.

Primary navigation

Alternative Site Languages


Skip the main content if you do not want to read it as the next section.

Main Content: ICCR AIDS report & responses

Interfaith Center on Corporate Responsibility report "Benchmarking AIDS": Company responses

In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets".  A PowerPoint summary of the report, which includes scores and "bottom line" assessment of each company, is available here.  The Business & Human Rights Resource Centre invited the 15 benchmarked companies to respond to the report; the results to date are indicated below.  Below the companies' responses are rejoinders by ICCR and Physicians for Social Justice (Nigeria) to the companies' responses, and a November 2006 follow-up report by ICCR.

Company responses / non-responses:

Abbott Laboratories statement [DOC]

AstraZeneca response [DOC]

Boehringer-Ingelheim response [DOC]

Bristol-Myers Squibb response [DOC]

Eli Lilly - declined to respond

Gilead Sciences - declined to respond

GlaxoSmithKline response [DOC]

Hoffman-La Roche - declined to respond

Merck response [PDF]

Novartis response [DOC]

Pfizer response [PDF]

sanofi-aventis: We invited sanofi-aventis to respond; no response has been received.

Schering-Plough - declined to respond

Tibotec (part of Johnson & Johnson) response [DOC]

Wyeth - press release sent in response to ICCR report

Rejoinders:

ICCR statement regarding the company responses (6 Nov 2006) [DOC]

Physicians for Social Justice (Nigeria) rejoinder to the company responses [DOC]
- Novartis response to Physicians for Social Justice [DOC]

Nov 2006 ICCR Update: 

Benchmarking AIDS: 2006 Year End Update [PDF]
- includes recent steps taken by Abbott, Gilead, GlaxoSmithKline, Novartis, Roche & recommendations for next steps for each of these companies


design image

The following page sections include static unchanging site components such as the page banner, useful links and copyright information. Return to the top of page if you want to start again.

Page Extras and footer content

End of page. You can return to the page content navigation from here.